Stephen William Watson Michnick
20Patents
9h-index
17Co-inventors
68Inventor score
Filing activity: Mar 10, 1995 → Aug 1, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6294330A | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 123 | Expired |
| US6270964A | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 98 | Expired |
| US6428951B1 | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 60 | Expired |
| US7166424B2 | Fragments of fluorescent proteins for protein fragment complementation assays | Physics | 13 | Expired |
| US7935493B2 | Protein fragment complementation assays for high-throughput and high-content screening | Emerging Cross-Sectional Technologies | 13 | Active |
| US6897017B1 | Vivo library-versus-library selection of optimized protein-protein interactions | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6828099B2 | Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 &bgr;-Lactamase | Physics | 11 | Expired |
| US6929916B2 | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7062219B2 | Protein fragment complementation assays for high-throughput and high-content screening | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6872871B2 | Mapping molecular interactions in plants with protein fragments complementation assays | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7160691B2 | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7306914B2 | Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7700375B2 | Fluorescent labeling of specific protein targets in vitro and in vivo | Physics | 5 | Expired |
| US7955832B2 | Composition useful for protein fragment complementation assays (PCA) using fragments of E. coli/TEM-1 β-lactamase | Physics | 4 | Active |
| US8192944B2 | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 4 | Active |
| US7855167B2 | In vivo screening of protein-protein interactions with protein-fragment complementation assays | Physics | 4 | Expired |
| US8101364B2 | Fragments of fluorescent proteins for protein fragment complementation assays | Physics | 2 | Active |
| US7989218B2 | Protein fragment complementation assays for the detection of biological or drug interactions | Emerging Cross-Sectional Technologies | 2 | Active |
| US5659012A | Peptide which binds SH.sub.2 domains of protein tyrosine phosphatase SH-PTP1 | Chemistry; Metallurgy | 2 | Expired |
| US7625700B2 | In vivo library-versus-library selection of optimized protein-protein interactions | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.